Familial studies have linked three areas of the genome to mitral valve prolapse risk. A new population-based study of 500 patients is casting the net more broadly. Results are due in 2018.
In this Q&A, Cleveland Clinic’s new Cardiothoracic Surgery Chair shares his vision for the department he now leads, the future of his specialty and collaboration in cardiovascular care.
Three Cleveland Clinic cardiac surgeons explain why the answer is “yes” in the wake of a new JACC study showing just how much volume and experience matter in mitral valve surgery.
Weekly transtelephonic monitoring of patients in a multicenter CTSN study reveals a difference between ablation methods where 72-hour Holter monitoring did not. The PI explores practice implications.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The appointment marks the latest milestone in a 20-year career at Cleveland Clinic marked by expertise in mitral valve surgery, robotics atrial fibrillation and more.
Give us two minutes, and cardiothoracic surgeon A. Marc Gillinov gives you essential outcomes takeaways from Cleveland Clinic’s nearly 3,000 heart valve procedures in 2015.
Despite their popularity, wrist-worn fitness trackers aren’t reliable for accurately monitoring heart rate, and accuracy varies among leading models. So reports one of the first-ever studies of the devices.
For a young Canadian with anterior leaflet mitral valve prolapse, the opportunity to undergo robotically assisted valve repair close to his family in the Middle East just couldn’t be beat.
Here’s the skinny on three new or emerging technologies that promise to make mitral valve procedures less invasive and/or more efficient.
A 1,000-case series provides reassurance that robotically assisted mitral valve surgery is safe and highly effective. Does this set the stage for comparison with emerging percutaneous interventions?